Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook

Teladoc Health Inc. (NYSE: TDOC ) shares are trading sharply lower during Thursday’s premarket session as investors digest second-quarter results and a cautious outlook that undercut the beat on earnings.

Teladoc Health stock is taking a hit today.

What’s behind TDOC decline? What Is Driving Teladoc’s Q2 Revenue Miss? Teladoc reported second-quarter revenue of $606.9 million (down 4% year-over-year) and a loss of 21 cents per share, while its third-quarter revenue guide of $569 million to $609 million landed below the Street view of $629.3 million.

The company also guided to a third-quarter loss of 30 cents per share to a loss of 20 cents per share versus expectations for a loss of 18 cents per share.

Teladoc’s segment split is amplifying the guidance hit, with Integrated Care up 1% to $394.3 million while BetterHelp fell 12% to $212.6 million, alongside management’s comment that cash-pay pressure intensified in late May and early June.

CEO Chuck Divita also pointed to the U.S. launch of Teladoc One, the company’s new connected care model, as a longer-term product push even as near-term demand wobbles.

Critical Price Levels To Watch For TDOC The premarket flush puts TDOC back below its shorter-term trend gauges, trading 20.6% below the 20-day SMA ($9.27) and 9.4% below the 50-day SMA ($8.12), which often turns recent "dip-buy" setups into "sell-the-rip" behavior.

It’s still 5.9% above the 100-day SMA ($6.95) and 6.6% above the 200-day SMA ($6.91), so the longer-term base from late spring is being tested rather than fully broken.

MACD is the cleaner momentum lens here: it’s below its signal line with a negative histogram, which suggests upside pressure is fading unless buyers can quickly reclaim that baseline.

In plain terms, MACD below the signal line typically means the recent uptrend is losing steam and rallies can stall sooner.

The moving-average structure is mixed: the 20-day SMA remains above the 50-day SMA (bullish), and the golden cross in June (50-day above 200-day) still argues the bigger trend improved earlier this summer.

But with the recent swing high and 52-week high both set in July, this gap-down style move increases the odds that July becomes a more durable pivot zone overhead.

Key Resistance: $8.00 — a round-number area that also sits near the 50-day moving averages, where rebounds can run into supply Key Support: $7.00 — a nearby round-number level sitting close to the 200-day EMA ($7.30) and the longer-term moving-average cluster TDOC Stock Price Activity During Thursday Premarket TDOC Stock Price Activity: Teladoc Health shares were down 19.83% at $7.36 during premarket trading on Thursday, according to Pro data.

Read Also: Congressman Makes First Stock Trade in Office: Here’s The Magnificent Seven Name He Sold Image: Shutterstock